FrancophonIA/ELRC3.0 huggingface dataset:
English: Dapagliflozin does not impair normal endogenous glucose production in response to hypoglycaemia.
Croatian: Dapagliflozin ne ometa normalnu endogenu proizvodnju glukoze kao odgovor na hipoglikemiju.
English: Taking this medicine with other medicines called sulphonylureas or with insulin can cause too low blood sugar levels (hypo-glycaemia), which may cause symptoms such as shaking, sweating and change in vision, and may affect your ability to drive and use machines.
Croatian: Uzimanje ovoga lijeka s drugim lijekovima koji se zovu sulfonilureje ili s inzulinom može izazvati preniske razine šećera u krvi (hipoglikemiju), što može dovesti do pojave simptoma poput drhtanja, znojenja i promjena vida te utjecati na sposobnost upravljanja vozilima i rada na strojevima.
English: Forxiga contains lactose (milk sugar).
Croatian: Forxiga sadrži laktozu (mliječni šećer).
English: These symptoms could be a sign of “diabetic ketoacidosis” - a problem you can get with diabetes because of increased levels of “ketone bodies” in your urine or blood, seen in tests.
Croatian: Ovi simptomi mogu biti znak „dijabetičke ketoacidoze“problema koji se može javiti uz šećernu bolest zbog povišenih razina „ketonskih tijela“ u mokraći ili krvi, što je vidljivo u nalazima pretraga.
English: “Type 2 diabetes mellitus” is the type of diabetes that usually starts when you are older.
Croatian: "Šećerna bolest tipa 2" je vrsta šećerne bolesti koja se obično javlja u starijoj dobi.
English: Maximum dapagliflozin plasma concentrations (Cmax) were usually attained within 2 hours after administration in the fasted state.
Croatian: Maksimalne koncentracije dapagliflozina u plazmi (Cmax) obično se dosežu u roku od 2 sata nakon primjene natašte.
English: It is not known if this medicine passes into human breast milk.
Croatian: Nije poznato izlučuje li se ovaj lijek u majčino mlijeko.
English: Difference from placebo c
Croatian: Razlika u odnosu na placebo c
English: The most commonly reported adverse reaction related to renal function was serum creatinine increases, the majority of which were transient and reversible (see section 4.8).
Croatian: Najčešće prijavljena nuspojava povezana s bubrežnom funkcijom bila je povišenje vrijednosti kreatinina u serumu, koje je u većini slučajeva bilo prolazno i reverzibilno (vidjeti dio 4.8).
English: Dapagliflozin did not show any toxicity in healthy subjects at single oral doses up to 500 mg (50 times the maximum recommended human dose).
Croatian: Dapagliflozin nije imao toksičnih učinaka u zdravih ispitanika kod primjene jednokratnih peroralnih doza do 500 mg (50 puta više od maksimalne dopuštene doze u ljudi).
English: • if you have a kidney problem - your doctor may ask you to take a different medicine.
Croatian: • ako imate tegoba s bubrezima - u tom slučaju Vaš liječnik može zatražiti da uzimate drugi lijek.
English: Experience in NYHA class I-II is limited, and there is no experience in clinical studies with dapagliflozin in NYHA class III-IV.
Croatian: Iskustvo primjene pri NYHA stupnjevima I-II je ograničeno, dok u kliničkim ispitivanjima s dapagliflozinom nema iskustva pri NYHA stupnjevima III-IV.
English: In general, no dosage adjustment is recommended based on age.
Croatian: U načelu se ne preporučuje prilagođavati dozu na temelju dobi.
English: In in vitro studies, dapagliflozin neither inhibited cytochrome P450 (CYP) 1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP3A4, nor induced CYP1A2, CYP2B6 or CYP3A4.
Croatian: U ispitivanjima in vitro dapagliflozin nije inhibirao izoenzime citokroma P450 (CYP) 1A2, CYP2A6, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP3A4 niti je inducirao CYP1A2, CYP2B6 i CYP3A4.
English: The renal pelvic and tubular dilatations observed in juvenile animals did not fully reverse within the approximate 1-month recovery period.
Croatian: Proširenje bubrežne nakapnice i tubula primijećeno u mladih životinja nije se u potpunosti povuklo u razdoblju oporavka u trajanju od otprilike mjesec dana.
English: These changes are not considered to be clinically meaningful.
Croatian: Ove se promjene ne smatraju klinički značajnima.
English: In the clinical program, 34.4% of subjects had a history of cardiovascular disease (excluding hypertension) at baseline and 67.9% had hypertension.
Croatian: U kliničkom je programu na početku liječenja 34,4% ispitanika imalo neku kardiovaskularnu bolest (osim hipertenzije) u anamnezi, a njih 67,9% je imalo hipertenziju.
English: Available epidemiological data for pioglitazone suggest a small increased risk of bladder cancer in diabetic patients treated with pioglitazone.
Croatian: Dostupni epidemiološki podaci za pioglitazon ukazuju na blago povećan rizik od raka mjehura u bolesnika sa šećernom bolešću koji se liječe pioglitazonom.
English: It is not known if DKA is more likely to occur with higher doses of dapagliflozin.
Croatian: Nije poznato je li vjerojatnost pojave DKA veća pri višim dozama dapagliflozina.
English: It is unknown whether dapagliflozin and/or its metabolites are excreted in human milk.
Croatian: Nije poznato izlučuju li se dapagliflozin i/ili njegovi metaboliti u majčino mlijeko u ljudi.
English: Common (may affect up to 1 in 10 people)
Croatian: Česte (mogu se javiti u do 1 na 10 osoba)
English: Dapagliflozin is a highly potent (Ki: 0.55 nM), selective and reversible inhibitor of sodium-glucose co-transporter 2 (SGLT2).
Croatian: Dapagliflozin je vrlo snažan (Ki: 0,55 nm), selektivan i reverzibilan inhibitor suprijenosnika natrijaglukoze 2 (engl. sodium-glucose co-transporter 2, SGLT2).
English: When considering the cases of tumours occurring in the different organ systems, the relative risk associated with dapagliflozin was above 1 for some tumours (bladder, prostate, breast) and below 1 for others (e.g. blood and lymphatic, ovary, renal tract), not resulting in an overall increased tumour risk associated with dapagliflozin.
Croatian: Kad su se razmatrali slučajevi tumora u različitim organskim sustavima, relativni rizik povezan s dapagliflozinom za neke je tumore bio iznad 1 (mokraćni mjehur, prostata, dojka), a za druge ispod 1 (npr. krv i limfa, jajnici, bubrežni trakt), što nije povećalo ukupan rizik od tumora povezan s dapagliflozinom.
English: SGLT2 is the predominant transporter responsible for reabsorption of glucose from the glomerular filtrate back into the circulation.
Croatian: SGLT2 je glavni prijenosnik odgovoran za reapsorpciju glukoze iz glomerularnog filtrata u krvotok.
English: At 24 weeks, reductions in serum uric acid concentrations ranged from -48.3 to -18.3 micromoles/l (-0.87 to -0.33 mg/dl).
Croatian: U 24. tjednu se smanjenje koncentracije mokraćne kiseline u serumu kretalo od -48,3 do -18,3 mikromola/l (-0,87 do -0,33 mg/dl).
English: • Do not use this medicine after the expiry date, which is stated on the blister or carton after ‘EXP'.
Croatian: • Ovaj lijek se ne smije upotrijebiti nakon isteka roka valjanosti navedenog na blisteru iza „EXP“ i kutiji iza “Rok valjanosti“.
English: These subjects had detectable glucose in the urine for a dose-related period of time (at least 5 days for the 500 mg dose), with no reports of dehydration, hypotension or electrolyte imbalance, and with no clinically meaningful effect on QTc interval.
Croatian: U tih se ispitanika glukoza u mokraći mogla utvrditi tijekom razdoblja koje je ovisilo o dozi (najmanje 5 dana za dozu od 500 mg), ali nisu prijavljene dehidracija, hipotenzija ni neravnoteža elektrolita, kao ni klinički značajan učinak na QTc-interval.
English: Other side effects when taking Forxiga:
Croatian: Ostale nuspojave kod uzimanje lijeka Forxiga:
English: The risk of developing diabetic ketoacidosis may be increased with prolonged fasting, excessive alcohol consumption, dehydration, sudden reductions in insulin dose, or a higher need of insulin due to major surgery or serious illness.
Croatian: Rizik od razvoja dijabetičke ketoacidoze može biti povećan kod produljenog gladovanja, prekomjerne konzumacije alkohola, dehidracije, iznenadnog smanjenja doze inzulina ili povećane potrebe za inzulinom zbog velikog kirurškog zahvata ili ozbiljne bolesti.
English: Maternal toxicity was evident only at the highest dose tested, and limited to transient reductions in body weight and food consumption at dose.
Croatian: Toksičnost za majku primijećena je samo kod najviše ispitivane doze, a bila je ograničena na prolazna smanjenja tjelesne težine i unosa hrane pri toj dozi.
English: Hence, Forxiga can be administered with or without food.
Croatian: Stoga se Forxiga može uzimati s hranom ili bez nje.
English: 14 film-coated tablets 28 film-coated tablets 30x1 film-coated tablets 90x1 film-coated tablets 98 film-coated tablets
Croatian: 14 filmom obloženih tableta 28 filmom obloženih tableta 30 x 1 filmom obložena tableta 90 x 1 filmom obložena tableta 98 filmom obloženih tableta
English: The hazard ratio comparing dapagliflozin to comparator was 0.79 (95% Confidence interval [CI]: 0.58, 1.07), indicating that in this analysis Forxiga is not associated with an increase in cardiovascular risk in patients with type 2 diabetes mellitus.
Croatian: Omjer hazarda kod usporedbe dapagliflozina i usporednog lijeka bio je 0,79 (95% intervala pouzdanosti [CI]: 0,58; 1,07), što ukazuje na činjenicu da se u toj analizi Forxiga ne povezuje s povećanjem kardiovaskularnog rizika u bolesnika sa šećernom bolešću tipa 2.
English: Dapagliflozin is approximately 91% protein bound.
Croatian: Otprilike 91% dapagliflozina se veže za proteine.
English: Pharmacotherapeutic group: Drugs used in diabetes, Other blood glucose lowering drugs, excluding insulins, ATC code: A10BX09
Croatian: Farmakoterapijska skupina: Lijekovi za liječenje šećerne bolesti (antidijabetici), Ostali antidijabetici, izuzev inzulina, ATK oznaka: A10BX09
English: Fifty-two percent (52%) had mild renal impairment and 11% had moderate renal impairment.
Croatian: Pedeset i dva posto (52%) ispitanika imalo je blago oštećenje bubrežne funkcije, a 11% umjereno oštećenje bubrežne funkcije.
English: However, an increased exposure due to age-related decrease in renal function can be expected.
Croatian: Međutim, može se očekivati povećana izloženost zbog smanjene bubrežne funkcije zbog starije dobi.
English: There are no data from the use of dapagliflozin in pregnant women.
Croatian: Nema podataka o primjeni dapagliflozina u trudnica.
English: Renal function and risk of volume depletion should be taken into account (see sections 4.4 and 5.2).
Croatian: U obzir treba uzeti bubrežnu funkciju i rizik od deplecije volumena (vidjeti dijelove 4.4 i 5.2).
English: The increase in urinary volume was associated with a small and transient increase in urinary sodium excretion that was not associated with changes in serum sodium concentrations.
Croatian: Povećanje volumena mokraće povezano je s blagim i prolaznim povećanjem izlučivanja natrija mokraćom koje nije bilo udruženo s promjenama koncentracije natrija u serumu.
English: Dapagliflozin is not recommended for use in patients receiving loop diuretics (see section 4.5) or who are volume depleted, e.g. due to acute illness (such as gastrointestinal illness).
Croatian: Primjena dapagliflozina ne preporučuje se u bolesnika koji primaju diuretike Henleyeve petlje (vidjeti dio 4.5) ili kod kojih postoji deplecija volumena, primjerice, zbog akutne bolesti (poput gastrointestinalnih bolesti).
English: Forxiga is indicated in adults aged 18 years and older with type 2 diabetes mellitus to improve glycaemic control as:
Croatian: Forxiga je indicirana u odraslih u dobi od 18 i više godina sa šećernom bolešću tipa 2 za poboljšanje regulacije glikemije kao:
English: • if you experience rapid weight loss, feeling sick or being sick, stomach pain, excessive thirst, fast and deep breathing, confusion, unusual sleepiness or tiredness, a sweet smell to your breath, a sweet or metallic taste in your mouth, or a different odour to your urine or sweat, contact a doctor or the nearest hospital straight away.
Croatian: • ako iskusite nagli gubitak tjelesne težine, osjećaj mučnine ili povraćanje, bol u trbuhu, prekomjernu žeđ, ubrzano i duboko disanje, smetenost, neuobičajenu pospanost ili umor, zadah slatkog mirisa, slatki ili metalni okus u ustima, ili drugačiji miris mokraće ili znoja, odmah se javite liječniku ili u najbližu bolnicu.
English: Most infections were mild to moderate, and subjects responded to an initial course of standard treatment and rarely resulted in discontinuation from dapagliflozin treatment.
Croatian: Infekcije su većinom bile blage do umjerene pa su ispitanici odgovorili na početni ciklus standardnog liječenja i rijetko su morali prekinuti liječenje dapagliflozinom.
English: Gender The mean dapagliflozin AUCss in females was estimated to be about 22% higher than in males.
Croatian: Spol Procijenjeno je da je srednja vrijednost AUCss dapagliflozina u žena oko 22% veća nego u muškaraca.
English: The amount of glucose removed by the kidney through this mechanism is dependent upon the blood glucose concentration and GFR.
Croatian: Količina glukoze koja se ovim mehanizmom izluči putem bubrega ovisi o koncentraciji glukoze u krvi i brzini glomerularne filtracije (GFR).
English: The most commonly reported adverse reaction related to renal function was increased serum creatinine.
Croatian: Najčešće prijavljena nuspojava povezana s bubrežnom funkcijom bila je povišena vrijednost kreatinina u serumu.
English: • These are medicines taken by mouth for diabetes.
Croatian: • To su lijekovi za liječenje šećerne bolesti koji se uzimaju kroz usta.
English: • Your doctor may ask you to take Forxiga on its own if you are intolerant to metformin or together with other medicines to treat diabetes.
Croatian: • Liječnik može zatražiti od Vas da uzimate samo lijek Forxiga ako ne podnosite metformin, ili da ga uzimate s drugim lijekovima za liječenje šećerne bolesti.
English: • if you have a liver problem - your doctor may start you on a lower dose.
Croatian: • ako imate tegoba s jetrom - u tom slučaju liječnik može započeti liječenje nižom dozom.
English: Combination of a single dose of dapagliflozin 20 mg and simvastatin (a CYP3A4 substrate) resulted in a 19% increase in AUC of simvastatin and 31% increase in AUC of simvastatin acid.
Croatian: Kombinacija jedne doze dapagliflozina od 20 mg i simvastatina (supstrata CYP3A4) dovela je do povećanja AUC-a simvastatina za 19% i povećanja AUC-a simvastatinske kiseline za 31%.
English: The metabolism of dapagliflozin is primarily via glucuronide conjugation mediated by UDP glucuronosyltransferase 1A9 (UGT1A9).
Croatian: Metabolizam dapagliflozina prvenstveno se odvija putem glukuronidne konjugacije u kojoj posreduje UDP-glukuronoziltransferaza 1A9 (UGT1A9).
English: There is limited experience in clinical trials in patients with hepatic impairment.
Croatian: Malo je iskustva iz kliničkih ispitivanja u bolesnika s oštećenjem jetrene funkcije.
English: In patients where DKA is suspected or diagnosed, treatment with dapagliflozin should be discontinued immediately.
Croatian: U bolesnika u kojih se sumnja na DKA ili je ista dijagnosticirana, liječenje dapagliflozinom treba odmah prekinuti.
English: In combination with other glucose-lowering medicinal products including insulin, when these, together with diet and exercise, do not provide adequate glycaemic control (see sections 4.4, 4.5 and 5.1 for available data on different combinations).
Croatian: U kombinaciji s drugim lijekovima za snižavanje razine glukoze u krvi, uključujući inzulin, kada se tim lijekovima uz dijetu i tjelovježbu ne postiže dovoljno dobra regulacija glikemije (vidjeti dijelove 4.4, 4.5 i 5.1 za dostupne podatke o različitim kombinacijama).
English: The safety and efficacy of dapagliflozin in patients with type 1 diabetes have not been established and dapagliflozin should not be used for treatment of patients with type 1 diabetes.
Croatian: Sigurnost i djelotvornost dapagliflozina u bolesnika sa šećernom bolešću tipa 1 nisu ustanovljene te se dapagliflozin ne smije primjenjivati u liječenju bolesnika sa šećernom bolešću tipa
English: However, the differences in exposure were not considered clinically meaningful.
Croatian: Međutim, razlike u izloženosti nisu se smatrale klinički značajnima.
English: Adverse drug reactions related to increased creatinine were grouped (e.g. decreased renal creatinine clearance, renal impairment, increased blood creatinine and decreased glomerular filtration rate).
Croatian: Nuspojave na lijek povezane s povišenim razinama kreatinina su grupirane (npr. smanjen bubrežni klirens kreatinina, oštećenje bubrežne funkcije, povišenje razine kreatinina u krvi i smanjena brzina glomerularne filtracije).
English: Urinary glucose excretion may be associated with an increased risk of urinary tract infection; therefore, temporary interruption of dapagliflozin should be considered when treating pyelonephritis or urosepsis.
Croatian: Izlučivanje glukoze mokraćom može biti povezano s povećanim rizikom od infekcije mokraćnih puteva; stoga se kod liječenja pijelonefritisa ili urosepse mora razmotriti privremeni prekid liječenja dapagliflozinom.
English: Uncommon (may affect up to 1 in 100 people)
Croatian: Manje česte (mogu se javiti u do 1 na 100 osoba)
English: fPolyuria includes the preferred terms: pollakiuria, polyuria, urine output increased.
Croatian: Poliurija uključuje preferirane pojmove: polakizurija, poliurija, pojačano mokrenje.
English: In rats, dapagliflozin was neither embryolethal nor teratogenic at exposures up to 1,441 times the maximum recommended human dose.
Croatian: U štakora dapagliflozin nije bio embrioletalan ni teratogen pri izloženosti do 1441 puta većoj od one kod maksimalne preporučene doze u ljudi.
English: These infections were more frequent in females, and subjects with a prior history were more likely to have a recurrent infection.
Croatian: Te su infekcije bile češće u žena, dok je u ispitanika s infekcijom u anamnezi postojala veća vjerojatnost ponovnog razvoja infekcije.
English: • changes in the amount of cholesterol or fats in your blood (shown in tests)
Croatian: • promjene razine kolesterola ili masti u krvi (vidljivo iz nalaza pretraga)
English: Considering the lack of tumour findings in non-clinical studies as well as the short latency between first drug exposure and tumour diagnosis, a causal relationship is considered unlikely.
Croatian: S obzirom na to da u pretkliničkim istraživanjima nisu utvrđeni tumori kao i na kratkotrajnu latenciju između prvog izlaganja lijeku i dijagnoze tumora, uzročna povezanost se smatra malo vjerojatnom.
English: Initiation of dapagliflozin therapy in this population is not recommended (see sections 4.2 and 5.2).
Croatian: U toj se populaciji ne preporučuje započinjati liječenje dapagliflozinom (vidjeti dijelove 4.2 i 5.2).
English: Forxiga should not be used in patients with type 1 diabetes mellitus or for the treatment of diabetic ketoacidosis.
Croatian: Forxiga se ne smije primjenjivati u bolesnika sa šećernom bolešću tipa 1 ni za liječenje dijabetičke ketoacidoze.
English: Forxiga 5 mg tablets and Forxiga 10 mg tablets are available in aluminium blisters in pack sizes of 14, 28 or 98 film-coated tablets in non-perforated calendar blisters and 30x1 or 90x1 film-coated tablets in perforated unit dose blisters.
Croatian: Forxiga 5 mg tablete i Forxiga 10 mg tablete dostupne su u aluminijskim blisterima u pakiranjima od 14, 28 ili 98 filmom obloženih tableta u neperforiranim kalendarskim blisterima te pakiranjima od 30x1 ili 90x1 filmom obloženih tableta u perforiranim blisterima djeljivima na jedinične doze.
English: Rates of adverse events including dehydration or hypotension were similar to placebo, and there were no clinically meaningful dose-related changes in laboratory parameters, including serum electrolytes and biomarkers of renal function.
Croatian: Stope štetnih događaja, uključujući dehidraciju i hipotenziju, bile su podjednake kao u ispitanika koji su primali placebo, a nisu primijećene klinički značajne promjene laboratorijskih parametara povezane s dozom, uključujući vrijednosti elektrolita u serumu i biokemijske pokazatelje bubrežne funkcije.
English: The most frequently reported adverse reaction was hypoglycaemia, which depended on the type of background therapy used in each study.
Croatian: Najčešće prijavljena nuspojava bila je hipoglikemija, koja je ovisila o vrsti osnovnog liječenja koje se primjenjivalo u svakom pojedinom ispitivanju.
English: Dapagliflozin may add to the diuretic effect of thiazide and loop diuretics and may increase the risk of dehydration and hypotension (see section 4.4).
Croatian: Dapagliflozin može pojačati diuretski učinak tiazida i diuretika Henleyeve petlje te povećati rizik od dehidracije i hipotenzije (vidjeti dio 4.4).
English: Patients should be alerted to the risk of hypoglycaemia when dapagliflozin is used in combination with a sulphonylurea or insulin.
Croatian: Bolesnike treba upozoriti na rizik od hipoglikemije kod primjene dapagliflozina u kombinaciji sa sulfonilurejom ili inzulinom.
English: Insulin and insulin secretagogues
Croatian: Inzulin i inzulinski sekretagozi
English: Once-daily treatment with dapagliflozin resulted in statistically significant (p < 0.0001) reductions in HbA1c compared to placebo (Table 2).
Croatian: Liječenje dapagliflozinom jedanput na dan rezultiralo je statistički značajnim (p < 0,0001) sniženjem HbA1c u usporedbi s placebom (Tablica 2).
English: No dose adjustment is recommended.
Croatian: Ne preporučuje se prilagodba doze.
English: Dapagliflozin is extensively metabolised, primarily to yield dapagliflozin 3-O-glucuronide, which is an inactive metabolite.
Croatian: Dapagliflozin se u velikoj mjeri metabolizira, pri čemu se prvenstveno stvara dapagliflozin 3-O-glukuronid, koji je neaktivan metabolit.
English: These differences were not considered to be clinically meaningful.
Croatian: Ove se razlike nisu smatrale klinički značajnima.
English: Forxiga contains the active substance dapagliflozin.
Croatian: Forxiga sadrži djelatnu tvar dapagliflozin.
English: If any of the above applies to you (or you are not sure), talk to your doctor, pharmacist or nurse before taking Forxiga.
Croatian: Ako se nešto od navedenog odnosi na Vas (ili niste sigurni), obratite se svom liječniku, ljekarniku ili medicinskoj sestri prije nego uzmete lijek Forxiga.
English: Cardiovascular death, MI and stroke were observed with a hazard ratio of 0.77 (95% CI: 0.54, 1.10).
Croatian: Kod smrti zbog kardiovaskularnog uzroka, infarkta miokarda i moždanog udara primijećen je omjer hazarda od 0,77 (95% CI: 0,54; 1,10).
English: During clinical trials, the overall proportion of subjects with malignant or unspecified tumours was similar between those treated with dapagliflozin (1.50%) and placebo/comparator (1.50%), and there was no carcinogenicity or mutagenicity signal in animal data (see section 5.3).
Croatian: Tijekom kliničkih ispitivanja ukupan udio ispitanika sa zloćudnim ili nespecificiranim tumorima bio je podjednak među bolesnicima liječenim dapagliflozinom (1,50%) i onima koji su primali placebo/usporedni lijek (1,50%), a u podacima iz istraživanja na životinjama nije bilo znakova kancerogenosti i mutagenosti (vidjeti dio 5.3).
English: cVulvovaginitis, balanitis and related genital infections includes, e.g. the predefined preferred terms: vulvovaginal mycotic infection, vaginal infection, balanitis, genital infection fungal, vulvovaginal candidiasis, vulvovaginitis, balanitis candida, genital candidiasis, genital infection, genital infection male, penile infection, vulvitis, vaginitis bacterial, vulval abscess.
Croatian: Vulvovaginitis, balanitis i srodne genitalne infekcije uključuju npr. unaprijed određene preferirane pojmove: vulvovaginalna gljivična infekcija, vaginalna infekcija, balanitis, gljivična genitalna infekcija, vulvovaginalna kandidijaza, vulvovaginitis, kandidalni balanitis, genitalna kandidijaza, genitalna infekcija, genitalna infekcija u muškaraca, infekcija penisa, vulvitis, bakterijski vaginitis, apsces vulve.